Pharmaceuticals
PharmAthene Reports Third Quarter 2009 Financial and Operational Results
Published in Vaccine Weekly, November 25th, 2009
For the third quarter of 2009, PharmAthene recognized revenues of $6.8 million compared to $10.7 million in the same period of 2008. For the nine months ended September 30, 2009 and 2008, the Company reported revenues of $20.4 million and $27.4 million, respectively. Revenues consisted primarily of contract funding from the U.S. government for the development of SparVax™, Valortim=AE and Protexia=AE.
Research...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-11-25)
More Articles from Vaccine Weekly
- Ludwig-Maximilians-Universitat Munchen
Hoping for a fluorescent basket case - University of Montreal
'Emotions increase or decrease pain': researchers - University of Wisconsin-Madison
FDA-approved drugs eliminate, prevent cervical cancer in mice - Anthrax
Research from Food & Drug Administration has provided new information about anthrax - Aspergillus Fumigatus
Research from University of Wurzburg reveals new findings on aspergillus fumigatus - Bordetella
New Bordetella research has been reported by J.H. Shakib et al - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
